Mass Tort vs. Class Action: They're Not the Same Thing
"It's a class action." People say this about nearly any lawsuit with a lot of plaintiffs, and most of the time, for the big product-injury cases at least, they're wrong. The talc litigation, the firefighting-foam cases, the drug and device fights, these are mass torts, and a mass tort is a fundamentally different animal from a class action. The distinction isn't academic. It determines whether you keep control of your own case, whether you're bound by an outcome you had no say in, and how much you might actually recover.
Getting this wrong leads people to badly mistaken assumptions, that their individual injury will get them a tiny check, or that they're stuck with whatever some representative plaintiff agrees to. So here's the real difference, when each tool gets used, and the instructive case where the two collide.
The class action: one case, one outcome, everyone bound
A class action is, at its core, one lawsuit that stands in for many. A small number of named plaintiffs, the class representatives, sue on behalf of a large group, the class, of people who were all harmed in essentially the same way. The court has to formally certify the class, finding among other things that the members' claims share common questions that predominate over their individual differences, and that one case can fairly resolve them all.
The defining features flow from that structure. There's one outcome that binds the entire class. If the class wins or settles, every class member is generally bound by that result, whether or not they participated, whether or not they even knew about it, unless they affirmatively opted out during a window the court provides. Individual recovery is often modest, sometimes very modest, because the total is divided among a large class and the individual harms are typically small and similar. And the class members mostly aren't active participants; the representatives and class counsel drive the case, and everyone else is along for the ride.
This is the right tool when the harm is uniform and individually small. A company overcharged millions of customers a few dollars each. A data breach exposed a database. A security misrepresentation hit thousands of shareholders the same way. No individual's loss is big enough to justify their own lawsuit, but aggregated, the wrong is enormous, and a class action lets it be addressed in one efficient case. The modest per-person payout is acceptable precisely because the individual harm was modest.
The mass tort: many cases, individual injuries, your claim stays yours
A mass tort is the opposite design. Instead of one lawsuit standing in for many, it's many individual lawsuits, each belonging to its own plaintiff, brought because a lot of people were harmed by the same product or conduct, but harmed differently.
That difference, the individuality of the injuries, is the whole reason mass torts exist as a separate thing. In a drug or chemical case, one person developed one cancer, another developed a different one, a third had a milder injury, a fourth a catastrophic one. Their exposures differ, their medical histories differ, their damages differ enormously. Those claims are too individual to be jammed into a single class with one binding outcome, because there's no uniform harm to certify around. So instead, each person files their own case, keeps their own lawyer, and retains their own individual claim and individual damages.
These individual cases usually get organized for efficiency through the MDL process, pooled before one judge for the common pretrial work, but pooling them is not merging them. Each plaintiff's case remains separate. Nobody is automatically bound by another plaintiff's result. The recovery isn't a small slice of a divided pot; it's tied to your specific injury and damages, which is why mass-tort recoveries for serious injuries can be substantial in a way class-action per-person payouts usually aren't. You're an active party with your own claim, not a passive member of a class.
This is the tool for serious, individualized personal injury, the defective drug that hurt people in different ways, the toxic exposure that caused varying cancers, the device that failed differently in different patients. The injuries are too big and too varied for a class; each deserves its own valuation.
The differences that actually matter to you
Lay the two side by side and the practical stakes come into focus.
Control of your case. In a class action, the representatives and class counsel run it; you mostly watch. In a mass tort, it's your case, with your lawyer, and your individual facts drive your outcome. If you want a say, the mass tort gives you one in a way the class action doesn't.
Whether you're bound by others' decisions. In a class action, you're generally bound by the class outcome unless you opted out in time. In a mass tort, another plaintiff's verdict or settlement doesn't automatically bind you; your case is yours to resolve.
Size of recovery. Class-action per-person payouts are often small because the harm was small and the pot is divided widely. Mass-tort recoveries track your individual injury, so a serious injury can mean a serious recovery, valued on your specific facts rather than averaged across a huge class.
The trade-off. The class action's strength is reaching small, uniform harms that could never justify individual suits, its weakness is the modest individual payout and loss of control. The mass tort's strength is individualized justice for serious, varied injuries, its cost is that it's slower and more complex, because thousands of individual cases have to be worked through rather than resolved in one stroke.
Where they collide: the Roundup situation
The cleanest way to see the distinction is a case where the two mechanisms are actually colliding, and the Roundup litigation in 2026 is exactly that. For years, Roundup has been a classic mass tort: tens of thousands of individuals, each alleging the weedkiller caused their non-Hodgkin lymphoma, each with their own case, producing a string of individual jury verdicts ranging from modest to enormous. Individual claims, individual outcomes, the mass-tort pattern.
But the manufacturer has now proposed resolving the whole thing, including future claims, through a class-action settlement, a multibillion-dollar class deal that would bind class members unless they opt out by a deadline. That's the controversial part, and it's controversial precisely because of the distinction in this article. Using a class-action mechanism, with its binding-unless-you-opt-out feature, to resolve what has been individualized personal-injury litigation raises hard questions: can future claimants, people not yet sick, fairly be bound by a class settlement negotiated now? Objectors have challenged it on exactly those grounds. We track the specifics in our Roundup litigation coverage, but for understanding the two tools, it's the perfect illustration: a mass tort being funneled into a class-action resolution, with all the tension that creates between individualized claims and collective, binding outcomes.
How to tell which one you're in
If you're trying to figure out whether your situation is a class action or a mass tort, a few questions sort it quickly.
How serious and individual is the injury? A small, uniform harm shared by many, an overcharge, a fee, a data exposure, points to a class action. A serious personal injury that varies from person to person, a cancer, an organ injury, a device failure, points to a mass tort.
Do you have your own lawyer and your own case? If you're retaining a lawyer who's handling your individual claim, you're almost certainly in mass-tort territory. If you got a notice in the mail saying you're part of a class and can opt out, that's a class action.
Will your recovery depend on your specific injury, or is it a set or divided amount? Individualized valuation means mass tort. A divided pot or a fixed per-person amount means class action.
The reason this matters, beyond getting the vocabulary right, is that it shapes your expectations and your strategy. If you have a serious injury from a product and you assume it's a class action, you might expect a small check and feel there's nothing to do but wait. Recognizing it as a mass tort tells you the opposite: your individual injury has its own value, you keep your own claim, you're not bound by strangers' outcomes, and the documentation and specifics of your case actually matter. Most of the big product-injury fights you read about are mass torts, not class actions, and knowing the difference is the first step to understanding where you actually stand.